Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
DN-101 and Taxotere in Advanced NSCLC
NCT00066885Phase 2Completed
- Sponsor
- Novacea
- Start
- Jun 2003
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of calcitriol in non-small cell lung cancer (NSCLC), sponsored by Novacea. Primary endpoint: Maximum Tolerated Dose. Started Jun 2003; status: completed.
02
Drugs
calcitriol
03
Conditions
non-small cell lung cancer (NSCLC)
Beyond the preview
Go deeper on NCT00066885.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00066885.